ARCHIVES

Cyclamate Committee Finds No Proof Of Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003